Archived 21: National Advisory Committee on Immunization statement: Interim guidance on booster COVID-19 vaccine doses in Canada [2021-10-29]

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2021) on “Archived 21: National Advisory Committee on Immunization statement: Interim guidance on booster COVID-19 vaccine doses in Canada [2021-10-29]”. Evidence-based recommendations of the need for and benefit of a booster dose in the Canadian context to facilitate timely decision-making for publicly funded vaccine programs at provincial and territorial levels.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.